RK

Ruby Kumari

Active Director Director DIN 08161044
DIN 08161044 First appointment Jun 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Ruby Kumari

Data last updated:

Ruby Kumari is a Director at Suhabi Biotech Private Limited (since 2018). The company operates in Trading. Suhabi Biotech Private Limited reported revenue of ₹5.1 Lakh (FY 2025).

DIN 08161044
Primary Designation Director
Industry Trading
First Appointment 19 Jun 2018
Oldest Company Age 8 yrs
Largest company Suhabi Biotech Private Limited · ₹5.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Suhabi Biotech Private Limited U51909BR2018PTC038512
Director19 Jun 20182018₹5.1 Lakh (FY 2025)Active

Board colleagues of Ruby Kumari

NameDINCompanyDesignation
Supriya Kumar08161043Suhabi Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Suhabi Biotech Private Limited
Premium access

Shareholding and investment profile for Ruby Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruby Kumari

Ruby Kumari currently holds 1 directorship: Suhabi Biotech Private Limited (Director, since 19 Jun 2018, revenue ₹5.1 Lakh (FY 2025)).

Ruby Kumari was first appointed on 19 Jun 2018 as Director at Suhabi Biotech Private Limited.

The current boards of Ruby Kumari's companies include Supriya Kumar (Suhabi Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available